BioPharmSignal logoBioPharmSignal
LiveFeedPDUFA CalendarUse CasesBlogPricing

Blog Tag

Drug Development

7 articles tagged with Drug Development. The newest post is from Jun 1, 2026.

Back to all tagsBack to blog
06/01/2026

FDA's Real-Time Trial Data and AI Plan Could Change Biotech Timelines

FDA wants to use real-time data and AI to speed up clinical trials. Here is what the proposal could mean for biotech timelines, capital efficiency, and investors.

04/19/2026

What Does MOA Mean in Biotech News?

Learn what MOA means in biotech, why mechanism of action matters, and how it helps investors interpret drug development and news.

04/17/2026

What Is Combination Therapy?

Learn what combination therapy means in biotech, why it matters in oncology and chronic disease, and how it shapes trial and market strategy.

03/31/2026

What Is Fast Track Designation?

Learn what fast track designation means in biotech, why it matters for serious diseases, and how it can support a quicker development path.

03/30/2026

What Is Breakthrough Therapy Designation?

Learn what breakthrough therapy designation means, why it matters in biotech, and how it can speed development and regulatory interaction.

03/26/2026

What Is an IND and Why Does It Matter in Drug Development?

Learn what an IND is, why it matters in biotech drug development, and how it signals the beginning of human clinical testing.

03/25/2026

Drug Development in Biotech: From Discovery to Approval

Learn the full biotech drug development process from discovery to approval, including preclinical work, clinical phases, filing, review, and launch.

BioPharmSignal ©2026

Track biotech catalysts, news, and alerts in one place.

Product

  • Pricing
  • LiveFeed
  • PDUFA Calendar

Integrations

  • Feishu / Lark Integration
  • Slack Integration
  • Discord Integration
  • DingTalk Integration

Compare

  • Compare
  • vs BioPharmCatalyst
  • vs Google Alerts
  • vs Feedly

Resources

  • Use Cases
  • About
  • Blog
  • Privacy
  • Terms
  • Sitemap
Information only - not investment advice.